The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Ledina A.V.

V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation, Moscow, Russia

Cytomegalovirus and papillomavirus infections: Possibilities for treatment and pregravid preparation with a plant-based antiviral drug

Authors:

Ledina A.V.

More about the authors

Read: 14739 times


To cite this article:

Ledina AV, Ledina AV. Cytomegalovirus and papillomavirus infections: Possibilities for treatment and pregravid preparation with a plant-based antiviral drug. Russian Bulletin of Obstetrician-Gynecologist. 2015;15(4):12‑17. (In Russ.)
https://doi.org/10.17116/rosakush201515412-17

Recommended articles:
Immu­nology of the cervix in normal and pathological conditions (literature review). Russian Journal of Human Reproduction. 2024;(5):108-117
Modern methods of treatment of latent form of HPV infe­ction: clinical obse­rvation. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):425-429

References:

  1. Virology. Moscow: Meditshina 1996; 480. (In Russ.).
  2. The molecular biology of viruses and antiviral therapy. Minsk: Vysshaya shkola 2005; 208. (In Russ.).
  3. Vikulov G.Kh. Human herpes virus infection in the new millennium: classification , epidemiology and social health value. Epidemiologiya i infektsionnie bolezni. Aktual’nye voprosy. 2014; 3: 35—40. (In Russ.).
  4. Feldman D M, Timms D, Borgida A F. Toxoplasmosis, parvovirus, and cytomegalovirus in pregnancy. Clin Lab Med. 2010; 30: 3: 709—720.
  5. Nikonov A.P., Astsaturova O.R. Cytomegalovirus infection and pregnancy. Ginekologiya. 2007; 9: 1. (In Russ.).
  6. Rafailidis P I, Mourtzoukou E G, Varbobitis I C, Falagas M E. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J. 2008; 27: 5: 47.
  7. Nordoy I. Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infection. Clin Exp Immunol 2000; 120: 2: 333—337.
  8. van den Berg A P, van der Bij W, van Son W J. Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation - a report of 130 consequtive patients. Transplantation 1989; 48: 991—996.
  9. Nelson C T, Demmler G J. Cytomegalovirus infection in the pregnant mother, fetus and newborn infant. Clin Perinatol 1997; 24: 1: 151—160.
  10. Prilepskaya V.N., Nazarova N.M., Sulamanidze L.A., Burmenskaya O.V., Trofimov D.Yu., Pavlovich S.V. Anogenital diseases associated with HPV infection. Ginekologiya. 2015; 17: 1: 4—7. (In Russ.).
  11. Safrpnnikova N.R., Chernysh S.I, Fomin Yu.A., Ermolenko D.K. Human papillomavirus infection: new approaches to treatment. TERRA MEDICA NOVA 2010; 2; 31—35. (In Russ.).
  12. Podzolkova N.M., Rogovskaya S.I., Fadeev I.E. Human papillomavirus infection: what’s new? Ginekologiya. 2011; 13: 5: 39—45. (In Russ.).
  13. Serov V.N., Tverdikova M.A., Tyutyunnik V.L. Genital HPV infection: the basic principles of treatment. Russkii medicinskii zhurnal. 2010; 18: 19: 1170—1173. (In Russ.).
  14. Virology (characterization of pathogens, pathogenesis and diagnosis of viral infections). Minsk 2003; 76. (In Russ.).
  15. Virology. Moscow: Meditsina 1986; 336. (In Russ.).
  16. Encephalitis Eurasia. 2002; 438. (In Russ.).
  17. Dunkelberger J R, Song W C. Role and mechanism of action of complement in regulating T cell immunity. Mol Immunol. 2010; 47: 13: 2176—2186.
  18. Kak V, Sundareshan V, Modi J, Khardori N M. Immunotherapies in infectious diseases. Med Clin North Am. 2012; 96: 3: 455—474.
  19. Prokopenko E.I. Viral infections and kidney transplantation (review of the literature). Nefrologiya i dializ 2003; 5: 2. (In Russ.).
  20. Bedard J, May S, Lis M, Tryphonas L, Drach J, Huffman J, Sidwell R, Chan L, Bowlin T, Rando R. Comparative study of the anti-human cytomegalovirus activities and toxicies of a tetrahydrofuran phosphonate analogue of guanosine and cidofovir J Antimicrob Agents Chemother 1999; 43: 557—567.
  21. Kisteneva L.B., Cheshik S.G., Kolobukhina L.V., Okolysheva N.D. Cytomegalovirus infection in women with burdened obstetric history (pregravid preparation for pregnancy). Epidemiologiya i infekcionnie bolezni. Aktual’nye voprosy. 2014; 3: 25—29. (In Russ.).
  22. Shul’zhenko A.E. Clinical efficacy and safety of polioksidoniya in chronic recurrent infections caused by the herpes simplex virus. Immunologiya. 202; 6: 349—351. (In Russ.).
  23. Antashyan G.G. Complex treatment of diseases of the genitals caused by human papillomavirus. Vrach. 2010; 10: 62—65. (In Russ.).
  24. Kungurov N.V., Gerasimova N.M., Kuzovkova T.V., Evstigneeva N.P. Experience Ural antiherpetic center. Rossiiskii zhurnal kozhnikh I venericheskikh boleznei. 2001; 6: 59—63. (In Russ.).
  25. Masyukova S.A., Kozhushkov A.I., Glad’ko O.V., Omarova M.A., Pospelova O.L., Stovbun S.V. Clinical study of the effects of the drug «Panavir» in the treatment of genital herpes. Vestnik poslediplomnogo medicinskogo obrazovaniya. 2002; 4: 14—16. (In Russ.).
  26. Klimova R.R,, Fedorova N.E., Kozlov A.Yu., Medzhidova M.G., Matushevskaya E.V., Sabirova L.M. The impact of the drug on the course Panavir herpes viral infections in vitro. Vestnik dermatologii i venerologii. 2005; 6: 52—56. (In Russ.).
  27. Deryabin P.G., Isaeva E.I., Litvin A.S., Stovbun S.V., Sergienko V.I. Action panavir to experimental infection caused by a virus of gepatitis C in cell culture. Infektsii, peredavaemye polovym putem. 2003; 3: 31—33. (In Russ.).
  28. Panavir — new etiotropic treatment tick-borne encephalitis. The collection of articles based on the 67th international Scientific Student Conference them. NI Pirogov]. Ed. by prof. VV Novitsky MD LM. Ogorodova. 2008; 477. (In Russ.).
  29. Kuzovkova T.V., Gerasimova N.M., Kungurov N.V., Evstigneeva M.P., Chigvinceva E.A. Treatment and prevention of relapse in the treatment of severe genital herpes infection. Klinicheskaya dermatologiya i venerologiya. 2005; 2: 26—28. (In Russ.).
  30. Red’kin Yu.V., Dron’ E.V. Immune and cytokine status in patients with chronic viral hepatitis with antiviral and immunomodulator Panavir Galavit. Citokiny i vospalenie. 2007; 6; 1: 40—46. (In Russ.).
  31. Klimova R.R. The impact of the drug on panavir for herpesvirus infections in vitro. Vestnik dermatologii i venerologii. 2005; 6: 52—56. (In Russ.).
  32. Panavir in the treatment of viral infections. Panavir Ed. akad. RAMN, prof. VI Sergienko. Moscow 2005; 172. (In Russ.).
  33. Дамиров М.М., Созаева Л.Г., Полетова Т.Н., Кижаев Ю.Е., Кучеров В.А., Стовбун С.В., Сафронов А.Ю., Багаева М.И. Применение панавира, противовирусного препарата, в комплексной прегравидарной подготовке пациенток с привычной потерей плода. Российский вестник акушера-гинеколога. 2012; 3: 79—80. Damirov M.M., Sozaeva L.G., Poletova T.N., Kizhaev Yu.E., Kucherov V.A., Stovbun S.V., Safronov A.Yu., Bagaeva M.I. Use of panavir, an antiviral drug, in the comprehensive pregravid preparation of patients with recurrent fetal loss. Rossiiskii vestnik akushera-ginekologa. 2012; 3: 79—80. (In Russ.).
  34. Prilepskaya V.N., Ledina A.V., Korotkova N.A. Cytomegalovirus infection: possibility of therapy during pregnancy. Ginekologiya. 2014; 16: 3: 35—37. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.